Brian L Hood - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Brian L Hood

Showing results (81-90 of 103) with videos related to

Pageof 11

Sort By:

Human Cell|March 3, 2017

Establishment and characterization of a platinum- and paclitaxel-resistant high grade serous ovarian carcinoma cell linePang-Ning Teng, Nicholas W Bateman, Guisong Wang, et al.

Biology of Reproduction|February 20, 2015

Proteomics of the human endometrial glandular epithelium and stroma from the proliferative and secretory phases of the menstrual cycleBrian L Hood, Baoquan Liu, Addie Alkhas, et al.

Cancer Medicine|December 7, 2019

Jupiter microtubule-associated homolog 1 (JPT1): A predictive and pharmacodynamic biomarker of metformin response in endometrial cancersNicholas W Bateman, Pang-Ning Teng, Erica Hope, et al.

Clinical & Experimental Metastasis|November 2, 2023

The murine metastatic microenvironment of experimental brain metastases of breast cancer differs by host age in vivo: a proteomic studyAllison L Hunt, Imran Khan, Alex M L Wu, et al.

Cancers|March 25, 2022

Molecular Correlates of Venous Thromboembolism (VTE) in Ovarian CancerDeanna Glassman, Nicholas W Bateman, Sanghoon Lee, et al.

Journal of Proteome Research|March 10, 2015

Elevated AKAP12 in paclitaxel-resistant serous ovarian cancer cells is prognostic and predictive of poor survival in patientsNicholas W Bateman, Elizabeth Jaworski, Wei Ao, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 15, 2014

Erlotinib, erlotinib-sulindac versus placebo: a randomized, double-blind, placebo-controlled window trial in operable head and neck cancerNeil D Gross, Julie E Bauman, William E Gooding, et al.

Gynecologic Oncology|August 28, 2023

Metronomic dosing of ovarian cancer cells with the ATR inhibitor AZD6738 leads to loss of CDC25A expression and resistance to ATRi treatmentWei Ao, Hong Im Kim, Domenic Tommarello, et al.

Gynecologic Oncology|April 5, 2011

Proteomic analysis of stage I endometrial cancer tissue: identification of proteins associated with oxidative processes and inflammationG Larry Maxwell, Brian L Hood, Roger Day, et al.

Cancer|June 28, 2017

Race-specific molecular alterations correlate with differential outcomes for black and white endometrioid endometrial cancer patientsNicholas W Bateman, Elizabeth A Dubil, Guisong Wang, et al.

Pageof 11

Search research articles

Showing results (81-90 of 103) with videos related to

Sort By:

Pageof 11

Human Cell|March 3, 2017

Establishment and characterization of a platinum- and paclitaxel-resistant high grade serous ovarian carcinoma cell linePang-Ning Teng, Nicholas W Bateman, Guisong Wang, et al.

Biology of Reproduction|February 20, 2015

Proteomics of the human endometrial glandular epithelium and stroma from the proliferative and secretory phases of the menstrual cycleBrian L Hood, Baoquan Liu, Addie Alkhas, et al.

Cancer Medicine|December 7, 2019

Jupiter microtubule-associated homolog 1 (JPT1): A predictive and pharmacodynamic biomarker of metformin response in endometrial cancersNicholas W Bateman, Pang-Ning Teng, Erica Hope, et al.

Clinical & Experimental Metastasis|November 2, 2023

The murine metastatic microenvironment of experimental brain metastases of breast cancer differs by host age in vivo: a proteomic studyAllison L Hunt, Imran Khan, Alex M L Wu, et al.

Cancers|March 25, 2022

Molecular Correlates of Venous Thromboembolism (VTE) in Ovarian CancerDeanna Glassman, Nicholas W Bateman, Sanghoon Lee, et al.

Journal of Proteome Research|March 10, 2015

Elevated AKAP12 in paclitaxel-resistant serous ovarian cancer cells is prognostic and predictive of poor survival in patientsNicholas W Bateman, Elizabeth Jaworski, Wei Ao, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 15, 2014

Erlotinib, erlotinib-sulindac versus placebo: a randomized, double-blind, placebo-controlled window trial in operable head and neck cancerNeil D Gross, Julie E Bauman, William E Gooding, et al.

Gynecologic Oncology|August 28, 2023

Metronomic dosing of ovarian cancer cells with the ATR inhibitor AZD6738 leads to loss of CDC25A expression and resistance to ATRi treatmentWei Ao, Hong Im Kim, Domenic Tommarello, et al.

Gynecologic Oncology|April 5, 2011

Proteomic analysis of stage I endometrial cancer tissue: identification of proteins associated with oxidative processes and inflammationG Larry Maxwell, Brian L Hood, Roger Day, et al.

Cancer|June 28, 2017

Race-specific molecular alterations correlate with differential outcomes for black and white endometrioid endometrial cancer patientsNicholas W Bateman, Elizabeth A Dubil, Guisong Wang, et al.

Pageof 11